CG-102-12C

· Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CG-102-12C, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC) [NA]